KYMR ▼ -0.5% - Kymera Therapeutics, Inc.
$KYMR - Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial
29-OCT-2026 07:00 AM ET
Share this post
More filings for $KYMR
KYMR ▲ +4.6% - Kymera Therapeutics, Inc.Oct 28, 2026KYMR - Kymera Therapeutics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026KYMR ▼ -1.6% - Kymera Therapeutics, Inc.Oct 22, 2026KYMR ▲ +3.1% - Kymera Therapeutics, Inc.Sep 10, 2026KYMR - Kymera Therapeutics, Inc. - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026KYMR ▼ -0.3% - Kymera Therapeutics, Inc.Sep 2, 2026
View full $KYMR filing history →💬 Comments
Loading comments…
Leave a comment